These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23680075)

  • 1. Randomized clinical trial examining duration of voucher-based reinforcement therapy for cocaine abstinence.
    Kirby KC; Carpenedo CM; Dugosh KL; Rosenwasser BJ; Benishek LA; Janik A; Keashen R; Bresani E; Silverman K
    Drug Alcohol Depend; 2013 Oct; 132(3):639-45. PubMed ID: 23680075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended voucher-based reinforcement therapy for long-term drug abstinence.
    Carpenedo CM; Kirby KC; Dugosh KL; Rosenwasser BJ; Thompson DL
    Am J Health Behav; 2010; 34(6):776-87. PubMed ID: 20604701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
    Silverman K; Higgins ST; Brooner RK; Montoya ID; Cone EJ; Schuster CR; Preston KL
    Arch Gen Psychiatry; 1996 May; 53(5):409-15. PubMed ID: 8624184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency management for cocaine treatment: cash vs. vouchers.
    Festinger DS; Dugosh KL; Kirby KC; Seymour BL
    J Subst Abuse Treat; 2014 Aug; 47(2):168-74. PubMed ID: 24746956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.
    Higgins ST; Heil SH; Dantona R; Donham R; Matthews M; Badger GJ
    Addiction; 2007 Feb; 102(2):271-81. PubMed ID: 17222282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resets do not appear to increase the rate of adverse events or prolong relapse in voucher-based reinforcement therapy.
    Versek BE; Carpenedo CM; Rosenwasser BJ; Dugosh KL; Bresani E; Kirby KC
    J Subst Abuse Treat; 2010 Sep; 39(2):167-73. PubMed ID: 20598837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude.
    Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Psychopharmacology (Berl); 1999 Sep; 146(2):128-38. PubMed ID: 10525747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule of voucher delivery influences initiation of cocaine abstinence.
    Kirby KC; Marlowe DB; Festinger DS; Lamb RJ; Platt JJ
    J Consult Clin Psychol; 1998 Oct; 66(5):761-7. PubMed ID: 9803694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voucher-based reinforcement of opiate abstinence during methadone detoxification.
    Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K
    Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of contingent prizes versus vouchers in cocaine-using methadone patients.
    Petry NM; Alessi SM; Hanson T; Sierra S
    J Consult Clin Psychol; 2007 Dec; 75(6):983-91. PubMed ID: 18085914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study.
    Dunn KE; Sigmon SC; Thomas CS; Heil SH; Higgins ST
    J Appl Behav Anal; 2008; 41(4):527-38. PubMed ID: 19192857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of voucher-based reinforcement therapy for substance use disorders.
    Lussier JP; Heil SH; Mongeon JA; Badger GJ; Higgins ST
    Addiction; 2006 Feb; 101(2):192-203. PubMed ID: 16445548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.
    Gross A; Marsch LA; Badger GJ; Bickel WK
    Exp Clin Psychopharmacol; 2006 May; 14(2):148-56. PubMed ID: 16756418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
    Silverman K; Robles E; Mudric T; Bigelow GE; Stitzer ML
    J Consult Clin Psychol; 2004 Oct; 72(5):839-54. PubMed ID: 15482042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delay discounting is associated with treatment response among cocaine-dependent outpatients.
    Washio Y; Higgins ST; Heil SH; McKerchar TL; Badger GJ; Skelly JM; Dantona RL
    Exp Clin Psychopharmacol; 2011 Jun; 19(3):243-8. PubMed ID: 21517195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.
    Schmitz JM; Mooney ME; Moeller FG; Stotts AL; Green C; Grabowski J
    Drug Alcohol Depend; 2008 Apr; 94(1-3):142-50. PubMed ID: 18164144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attendance rates in a workplace predict subsequent outcome of employment-based reinforcement of cocaine abstinence in methadone patients.
    Donlin WD; Knealing TW; Needham M; Wong CJ; Silverman K
    J Appl Behav Anal; 2008; 41(4):499-516. PubMed ID: 19192855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.
    Higgins ST; Wong CJ; Badger GJ; Ogden DE; Dantona RL
    J Consult Clin Psychol; 2000 Feb; 68(1):64-72. PubMed ID: 10710841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude.
    Dallery J; Silverman K; Chutuape MA; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2001 Aug; 9(3):317-25. PubMed ID: 11534542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.
    Silverman K; Wong CJ; Umbricht-Schneiter A; Montoya ID; Schuster CR; Preston KL
    J Consult Clin Psychol; 1998 Oct; 66(5):811-24. PubMed ID: 9803700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.